We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
-9.42%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$743M
AUM Growth
-$64.7M
Cap. Flow
+$15.3M
Cap. Flow %
2.06%
Top 10 Hldgs %
50.59%
Holding
662
New
7
Increased
37
Reduced
82
Closed
529
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOGM
626
DELISTED
LogMein, Inc.
LOGM
-3
Closed
CHK
627
DELISTED
Chesapeake Energy Corporation
CHK
-8
Closed -$7K
SDRL
628
DELISTED
Seadrill Limited Common Stock
SDRL
-5
Closed
JCP
629
DELISTED
J.C. Penney Company, Inc.
JCP
-197
Closed
ARCH
630
DELISTED
Arch Resources, Inc.
ARCH
-2,515
Closed -$225K
AGN
631
DELISTED
Allergan plc
AGN
-17
Closed -$3K
S
632
DELISTED
Sprint Corporation
S
-464
Closed -$3K
ZAYO
633
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-206
Closed -$7K
AVP
634
DELISTED
Avon Products, Inc.
AVP
-1,000
Closed -$2K
AAC
635
DELISTED
AAC Holdings
AAC
-2,086
Closed -$16K
VSM
636
DELISTED
Versum Materials, Inc.
VSM
-14
Closed -$1K
NRE
637
DELISTED
NorthStar Realty Europe Corp.
NRE
-59
Closed -$1K
APC
638
DELISTED
Anadarko Petroleum
APC
-93
Closed -$6K
LLL
639
DELISTED
L3 Technologies, Inc.
LLL
-32
Closed -$7K
CLD
640
DELISTED
Cloud Peak Energy Inc
CLD
-800
Closed -$2K
MBFI
641
DELISTED
MB Financial Corp
MBFI
-4,222
Closed -$195K
TFCFA
642
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-65
Closed -$3K
SGYP
643
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-200
Closed
LOXO
644
DELISTED
Loxo Oncology, Inc
LOXO
-40
Closed -$7K
SEND
645
DELISTED
SendGrid, Inc.
SEND
-21
Closed -$1K
GOV
646
DELISTED
Government Properties Income Trust
GOV
-15
Closed
CCT
647
DELISTED
Corporate Capital Trust, Inc.
CCT
-1,732
Closed -$26K
AET
648
DELISTED
Aetna Inc
AET
-18
Closed -$4K
COL
649
DELISTED
Rockwell Collins
COL
-22
Closed -$3K
PX
650
DELISTED
Praxair Inc
PX
-48
Closed -$8K

Similar funds

Trilogy Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Trilogy Capital held 662 positions worth $743M, down 8% from $808M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trilogy Capital's Q4 2018 filing shows 7 new, 37 increased, 82 reduced and 529 closed positions. Its largest new stake was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M. The largest sale was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $13.2M.

By sector, the portfolio is most concentrated in Utilities at 1.4% of assets, down from 1.4% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Trilogy Capital's largest Q4 2018 buy was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M.
  • Trilogy Capital added most to State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2018, an estimated $12.8M increase.
  • Trilogy Capital's biggest Q4 2018 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $13.2M.
  • Trilogy Capital fully exited John Hancock Multifactor Mid Cap ETF in Q4 2018, selling an estimated $11.1M.
  • Trilogy Capital's ten largest holdings make up 51% of its $743M portfolio in Q4 2018.
  • Trilogy Capital opened 7 new positions and closed 529 in Q4 2018.
  • Trilogy Capital's portfolio value fell 8% quarter-over-quarter to $743M.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.